Hagop M. Kantarjian, MD – Ponatinib, Blinatumomab, and CD19

Hagop M. Kantarjian, MD. Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX In the featured video, renowned expert Hagop Kantarjian, MD, a professor at MD Anderson Cancer Center, delves into groundbreaking developments in the treatment of adult acute lymphoblastic leukemia (ALL). With a focus on … Continue reading Hagop M. Kantarjian, MD – Ponatinib, Blinatumomab, and CD19